News - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News


Pharmaceutical Technology Europe


News bites

Restructure at Merck KGaA

Merck KGaA has announced measures to reduce costs and increase efficiency to ensure the long-term success of its business model. The measures are expected to result in workforce reductions across all businesses and regions. The measures will be implemented in two phases.
http://PharmTech.com/merckrestructure

GSK recall

GSK recently recalled 394230 bottles of its antihypertensive drug DynaCirc CR (isradipine) controlled-release tablets. The lots were recalled due to concerns regarding the level of cGMP compliance and procedural controls related to line clearance during the packing process at a US-based facility of Novartis Consumer Health, where the product was made.
http://PharmTech.com/gskrecall

FDA's DTC guidance

The FDA has released a draft guidance for direct-to-consumer (DTC) television advertisements in the US. Companies will have to submit their TV ads for FDA review at least 45 days before dissemination. After reviewing, the FDA can recommend changes to protect consumers or to be more consistent with prescribing information.
http://PharmTech.com/TVads

Japanese vaccine venture

GlaxoSmithKline and Daiichi Sankyo have formed a joint venture hey claim will create the biggest vaccines company in Japan. The joint venture will seek to improve access to vaccinations in Japan, as well as introduce new vaccines and create better and more convenient combination vaccines. The new company will be called Japan Vaccine Co., Ltd.
http://PharmTech.com/JPvaccines


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here